MAKE YOUR FORTUNE
PARTNERING WITH US
TO LAUNCH A
PEPTIDE LIFE CENTER
IN YOUR COMMUNITY
Featuring our patented Triple-G Weight Loss Metabolic Reset Journey and advanced FDA-approved non-surgical skin tightening technologies.
Protected by U.S. Patent, our GLP-1 / GLP-2 / GLP-3 (Triple-G) weight loss medication is a major part of our 20-week Metabolic Reset Journey.
Weekly Injection with NO DOCTORS • NO PHARMACIES • NO PRESCRIPTIONS
"…the world's most powerful weight-loss drug…"
— The Atlantic
Est. 1857 · Pulitzer Prize-winning publication
Weekly Injection · No Doctors · No Pharmacies · No Prescriptions
THE SYSTEM IS BUILT TO KEEP
You Dependent
Prescription GLP-1 drugs cost $1,000–$1,500 per month. When patients stop, every pound returns. The pharmaceutical system profits from lifetime customers — not patients who get well.
Peptide Associates offers a fundamentally different model — a structured, time-limited 20-week Metabolic Reset Journey with a defined endpoint, no prescriptions, and a cost patients can actually afford.
The pharmaceutical system does not profit from patients who get well. It profits from lifetime customers on monthly prescriptions. Leading prescription GLP-1 drugs are priced accordingly — $1,200+ per month, ongoing doctor visits required, and when you stop, every pound returns by design.
Bariatric surgery costs $25,000–$35,000 with permanent risks. Fad diets fail 95% of the time by design. And unregulated online peptides lack quality control entirely. The market is broken — and that's exactly why this opportunity exists.
Insurance rarely covers it. Supply is inconsistent. Weight returns the moment you stop. Built-in dependency by design.
Permanent alteration of your digestive system. Long-term risks include malnutrition, ulcers, bowel obstruction, and more.
Studies confirm: 95% of diets fail. The industry profits from repeated failure — not your success.
Most sellers label products "not for human consumption." No quality control. No dosing accuracy. Real risk.
HOW THE PEPTIDE LIFE CENTER
Works
From the first free scan to a 20-week metabolic transformation — here is exactly how the patient journey flows through your clinic.
The Peptide Life Center model is built on one simple insight: give people undeniable proof that something is wrong, and they will take action to fix it.
That's what the free 60-second body composition scan does. It shows patients exactly where their fat is, how much lean muscle they're losing, their biological versus chronological age, and precisely how long it will take to fix. The data creates urgency. The program delivers results.
60-second scan. 25 metrics. Printed 2-page report. Perceived value: $499. Cost to clinic: nothing. Over 75% enroll same day.
Patient begins the 20-week Metabolic Reset Journey with a weekly self-injection at home. Starting dose wholesale: $72. Retail: $297–$497. 60%+ net margin.
Triple-G suppresses appetite, optimizes insulin efficiency, and elevates resting metabolic rate. 91% continue month after month.
Every weight-loss patient becomes a skin tightening prospect. Partners charge $149/session or $897 for 6 sessions — far below competitors' $500–$1,000.
WHY TRIPLE-G IS IN
A CLASS OF ITS OWN
GLP-3/Triple-G targets three distinct metabolic pathways simultaneously. No other therapy comes close. Physicians responded with spontaneous applause when Phase 3 data was presented.
"…the world's most powerful weight-loss drug…" — The Atlantic, Pulitzer Prize-winning publication.
GLP-3/Triple-G works by targeting three distinct metabolic pathways simultaneously. No other single therapy — prescription or otherwise — achieves this triple-action mechanism. When Phase 3 clinical data was presented at a major medical conference in 2023, physicians responded with spontaneous applause.
Mimics the GLP-1 hormone to reduce hunger, slow gastric emptying, and promote early satiety. The brain stops signaling hunger before the body needs fuel.
Enhances nutrient processing, improves insulin response, and reduces GI side effects commonly associated with pharmaceutical GLP drugs.
Increases resting metabolic rate — enabling the body to burn significantly more calories even at rest. The calorie-burning engine runs 24/7.
| Therapy | Mechanism | Avg. Weight Loss | Prescription? | Monthly Cost |
|---|---|---|---|---|
| Triple-G / GLP-3 (Peptide Associates) | GLP-1 + GIP + Glucagon | ~29% | No | ~$200–$497 |
| Semaglutide (GLP-1 Class) | GLP-1 only | ~15% | Yes | $1,000–$1,500+ |
| Tirzepatide (GLP-1/GIP Class) | GLP-1 + GIP | ~20% | Yes | $1,000–$1,200+ |
| Bariatric Surgery | Anatomical restriction | ~25–30% | Yes | $25,000–$35,000 one-time |
| Commercial Diet Programs | Calorie restriction | ~5–10% | No | $300–$1,000+ |
"…the world's most powerful weight-loss drug…"— The Atlantic (Pulitzer Prize-winning publication)
The Atlantic — Pulitzer Prize-Winning Publication
The Atlantic's landmark coverage brought international attention to GLP-3/Triple-G Phase 3 clinical trial results — results so dramatic that physicians responded with spontaneous applause when the data was first presented at a major medical conference in 2023.
The World's Most Powerful Weight-Loss Drug
You're not supposed to be able to buy Retatrutide — but some people have found a way. And its results are jaw-dropping.
"Patients lost on average 71 pounds — double what people lose on Ozempic. Some stopped because the drug was too effective."
— The Atlantic, January 2026 Phase 3 Clinical Trial Report"You're not supposed to be able to buy the world's most powerful weight-loss drug, but some people have found a way." So begins The Atlantic's exhaustive investigation into Retatrutide — nicknamed GLP-3 — a drug that is rewriting everything we thought we knew about obesity medicine.
As the nickname GLP-3 implies, retatrutide is like a GLP-1 drug — but more, more, more. It is more effective, has more modes of action, and induces more weight loss. It may in fact be the most powerful weight-loss drug ever created.
When early retatrutide data were presented at a medical conference in 2023, a scientist who was there told The Atlantic the usually staid audience burst into spontaneous applause.
Phase 3 Results: Double the Weight Loss
Two weeks ago, the first of the highly anticipated Phase 3 clinical-trial results corroborated the jaw-dropping initial numbers: patients lost on average 71 pounds, or 29 percent of their body weight — double what people lose on semaglutide, better known as Ozempic or Wegovy.
Some trial participants stopped retatrutide early because they had lost too much weight — because the drug was simply too effective.
A Biologist's 100-Pound Journey
As a biologist herself, Elizabeth was comfortable working with needles and reading scientific papers. She modeled her dosing regimen on the clinical-trial protocol. She has lost more than 100 pounds in the past two and a half years — first on older drugs and the last 50 or so on retatrutide.
"After a lifelong struggle with obesity, these are some of the most amazing events of my whole life."
Anticipation Reaches Fever Pitch
The frenzy over retatrutide has kicked into even higher gear since the Phase 3 results were announced this month. GLP-1 prescriptions shot up from about 1 million at the start of 2018 to about 9 million in 2022. Retatrutide, researchers believe, could dwarf those numbers.
The Atlantic has been published since 1857 and the Pulitzer Prize-winning monthly continues to investigate the stories that define our era.
7 SECRETS DOCTORS & BIG PHARMA
DON'T WANT YOU TO KNOW
About Triple-G / GLP-3
The prescription weight loss system is not designed to make you well. It is designed to keep you dependent. Here is what they are hoping you never find out.
The weight loss industry generates over $300 billion annually in the United States. Yet study after study confirms that 95% of diets fail. Those two facts don't coexist by accident.
The Prescription Drug System Is Designed to Keep You Paying — Not to Make You Well
Leading prescription GLP-1 and GLP-2 drugs cost $1,000–$1,500 per month, require ongoing doctor visits, and are frequently unavailable due to supply shortages. When patients stop taking them, every pound returns.
The Most Powerful Weight Loss Compound Ever Discovered Doesn't Require a Prescription
FDA guidelines classify peptides exceeding 40 amino acids as prescription drugs. Our proprietary GLP-3/Triple-G formula has been independently verified at 39 amino acids — keeping it within supplement classification, legal to distribute in all 50 states.
What's Being Sold Online Is Dangerous — and Most of It Is Illegal
Most online peptide sellers label products "not for human consumption." Peptide Associates operates at the opposite end of this spectrum: GMP-certified, ISO 5, third-party verified, with U.S.-based healthcare legal oversight and full product liability insurance.
Exercise Alone Will Not Save You — and Your Doctor Knows It
Research is unambiguous: exercise alone cannot drive significant weight loss. The New York Times reported that for every 100 calories people expect to burn working out, most actually net fewer than 72 after the body compensates. Triple-G addresses weight loss at the metabolic level. No grueling workout required.
Weight Loss Surgery Carries Risks Your Surgeon Probably Downplayed
Bariatric procedures run $25,000–$35,000. Long-term side effects include malnutrition, bowel obstruction, ulcers, hernias, and chronic vomiting. Compare that to a nonprescription weekly injection at home for a few hundred dollars a month.
The Free Scan That Shows Patients Exactly What's Happening Inside Their Body
A 60-second body composition scan checks 25 body metrics and produces a printed 2-page report on the spot. It costs the clinic nothing, carries a perceived value of $499, and helps patients see the problem clearly. Over 75% enroll the same day.
Most Weight-Loss Programs Are Designed for You to Fail — They Need You to Come Back
The Peptide Associates 20-week Metabolic Reset Journey breaks this cycle by resetting the underlying metabolic pathways that govern hunger and fat storage — not temporarily suppressing them.
Bonus Secret: The True Value of Safe, Effective, Affordable Weight Loss Is Almost Immeasurable
Confidence, relationships, metabolic health, financial savings, lean muscle preservation, skin tightening support, and a defined 20-week endpoint are all part of what patients are really seeking. The goal is not another temporary diet cycle — it is a genuine metabolic transformation that helps people step off the weight-loss merry-go-round.
Oprah Winfrey — Public Statement, 2024
"I've been on the medication for the past year and a half..."
After decades of public struggle with weight, Oprah Winfrey publicly credited GLP-class medications as the tool that finally worked — helping legitimize the entire category in the eyes of tens of millions of consumers.
Dr. Ania Jastreboff & Oprah Winfrey
Co-authors of Enough — 2026 Bestseller
Backed by Science · Discussed by Oprah · Changing Everything
"THE FUTURE OF
WEIGHT LOSS
HAS ARRIVED"
"Obesity is NOT a failure of willpower."
A groundbreaking 2026 bestseller reveals what millions are just beginning to understand:
PEPTIDE ASSOCIATES
Partnership
A practical breakdown of the business model, ownership structure, launch path, support system, compliance foundation, and investment terms. Read this before your call.
By the time a serious prospect reaches this section, the market is usually obvious. What matters next is the business relationship itself: what you own, what we provide, how patients are acquired, and how the model is protected in the field.
This is not a franchise. Partners own 100% of their local clinic. Peptide Associates supplies the protocol, product access, training, operating system, technology, and ongoing support. Our continuing compensation comes from wholesale medication margins, so our incentives stay tied to partner volume and patient retention.
A structured 20-week program built around the patented nonprescription GLP-3 / Triple-G formula, with clinical data showing ~29% average body weight loss and 91% monthly patient retention.
FDA-approved, non-invasive technology addresses loose skin caused by rapid weight loss. It becomes a natural second sale and an additive revenue stream for the clinic.
Partners pay a one-time $99,700 Re-earnable Performance Deposit, fully rebated back via deep discounts on already competitive wholesale pricing. This applies to the first clinic only; additional locations may be opened at no additional payment to us.
"We are selective. We work only with people we believe have what it takes to succeed. Not everyone qualifies."
We place only a small number of partners per state. Once an area is committed, it is closed. We encourage thorough due diligence, including conversations with our Marketing Director and current clinic owners already in operation.
As part of the Re-earnable $99,700 Performance Deposit, we are now including a FREE Skin Tightening Body Contouring Machine and a FREE Body Analysis Scan Machine for all new partners. Comparable equipment sells for upwards of $100,000+.
Call to discuss an additional MAJOR ad agency incentive - a $30,000 value - that includes: a custom video of your clinic, a personalized $5,000 world-class website built using our intellectual property, two months of digital advertising budget, and four months of paid SEO to drive Google traffic for "weight loss options" within a 30-mile radius of your location.
Model Your Million-Dollar Clinic
Adjust the assumptions below to model revenue, profit, payback period, and possible exit value for a Peptide Life Center partnership.
© 2026 George Tippetts. All rights reserved. This calculator, including its design, copy, calculation logic, formulas, source code, and interactive architecture, is proprietary to George Tippetts and may not be copied, redistributed, modified, displayed, transmitted, or commercially used without explicit written authorization.
Joe Webb Interviews
Lab Founder John Brewer
Joe Webb, CEO interviews John Brewer, Lab Founder, in depth about our new patented peptides, compliance and legal issues, testing and safety protocols and much more.
EVERY QUESTION PARTNERS ASK —
Answered
From legal classification and compliance to staffing, marketing, and wholesale pricing. Click any question to expand the answer.
These two streams work together naturally. Weight loss patients become skin tightening patients, creating multiple revenue opportunities from every person who walks through your door.
An absentee partner-investor could run a few clinics for a couple of years and then sell. Specialized niche health businesses like this typically sell at five times gross sales.
This triple-action mechanism is what makes it significantly more powerful than single- or dual-pathway therapies.
Call now: (941) 200-1200
INCREDIBLE IN-STORE
Lead Generation
Co-branded wellness kiosks placed inside major grocery, drug store, and blood lab chains — generating a continuous stream of qualified, motivated leads directly to your clinic.
Co-Branded Retail Placement
PLACED WHERE PATIENTS
ALREADY SHOP
Co-branded wellness kiosks put your clinic offer inside familiar retail, pharmacy, fitness, and lab environments where motivated shoppers already make health and wellness decisions.
CO-BRAND WITH
MAJOR RETAILERS
Kroger
Rite Aid
Esporta
Food Lion
Giant
Shaw's
Mariano's
Jewel-Osco
Smith's
Save Mart
ACME
Harris Teeter
Amigos
WinCo Foods
Food4Less
Ralph's
Fred Meyer
QFC
Pick'n Save
Piggly Wiggly+ Quest Diagnostics blood lab locations nationwide
Limited Availability · New Partners Only
YOUR COMPLETE
DIGITAL LAUNCH SYSTEM
Retail placement builds local visibility. This system gets them finding you online before they ever step foot in a store. Both channels work together.
for qualifying new partners
An area-specific patient acquisition site with lead capture, pre-call checklist, and automated follow-up.
A professionally scripted clinic video designed to pre-sell prospects before the consultation.
Custom logo, brand kit, business cards, official letterhead, and email signature so every patient-facing touchpoint looks professional from day one.
Full library of editable, high-converting ad templates for Meta, Instagram, and TikTok. Includes two months of digital advertising budget.
Launch support for digital advertising so the system can begin producing market awareness quickly.
Search architecture targeting weight-loss interest within your local service area.
Partner access to the marketing library, including body comp reports, patient flyers, referral cards, testimonial systems, and other clinic-ready assets.
Follow-up flows, optimization, and direct launch support for the clinic buildout.
Continuous funnel improvements, fresh creative assets, A/B testing, and technical maintenance so the launch system does not go stale.
Direct line to the buildout operator. No ticket queues or layers in between. When something needs to be built or fixed, it gets handled.
Included during the current enrollment window: this digital launch package complements the in-store kiosk strategy, giving new partners both local visibility and intent-driven digital patient acquisition.
BUILT THE Right Way
FROM THE START
Our laboratory, legal, and operational infrastructure is not an afterthought — it is the foundation that protects every partner, every patient, and the entire enterprise.
When you partner with Peptide Associates, you are backed by a compliance infrastructure that has been years in the making — and that no unqualified competitor can replicate.
FDA guidelines classify peptides over 40aa as prescription drugs. Our formula is independently verified at 39aa — maintaining supplement classification and legal distribution to all 50 states.
Our U.S.-based laboratory operates under GMP certification, ISO 5 cleanroom standards, and strict regulatory guidance.
The laboratory carries significant product liability insurance — protecting every partner, every patient, and the enterprise as a whole.
Our nonprescription GLP-1 / GLP-2 / GLP-3 medications are protected by five U.S. Patents. You partner with a proprietary system — not a commodity anyone can replicate.
Products sold exclusively through licensed partner clinics. Never direct-to-consumer. Never on Amazon. This structure maintains marketplace integrity and protects every partner's territory.
Our core team has worked together for over 17 years and has launched hundreds of clinics. This is an established, proven enterprise — not a startup with unverified claims.
All peptide products must be sourced exclusively through Nonprescription Clinical, LLC / Peptide Associates. GMP-certified, ISO 5, third-party verified batches only.
All products distributed must maintain their supplement classification. Partners may not make prescription-drug claims. All marketing must align with approved intellectual property.
All patients must complete a body composition scan prior to enrollment. Informed consent forms required. Partners must follow the 20-week protocol scripts as trained during onboarding.
At minimum one staff member must complete the Certified Wellness Coach course prior to seeing patients. All staff must complete the Peptide Associates onboarding training program before launch.
Partners must use approved marketing templates and scripts. No unauthorized health claims, before/after photos without consent, or unverified testimonials permitted.
Partners may not sell outside their designated territory or through any e-commerce channel. Products must be sold exclusively through the licensed partner clinic to end patients only.
"Our compliance infrastructure isn't a legal disclaimer. It's a competitive moat. No unqualified operator can build what we've built in a day, a month, or a year."
— Peptide Associates Compliance OverviewYOUR AREA
MAY STILL BE
AVAILABLE
We select only a small number of partners per state. Once an area is committed, it is gone. The entrepreneurs who act first own the patients, the relationships, and the profits.
THE GOLD RUSH
Is Here
Medical Marketing & Media's landmark investigation: $100B+ projected annually, Influencers like Joe Rogan and RFK Jr. driving mass awareness, and the professional-channel market just beginning to open.
Medical Marketing and Media
GET READY FOR THE
PEPTIDES GOLD RUSH
A heavy combination of influencers, deregulation, GLP-1 success stories and Do-It-Yourself medicine are driving the phenomenal growth in peptides. But are they safe?
Peptides are becoming a foundational part of the DIY health movement, spurred on by the success of GLP-1s.
"Influencers like Joe Rogan are driving interest in the use of peptides."
THE ROGAN EFFECT

Influencers don't get much more influential than Joe Rogan. With nearly 20 million Instagram followers and over 35 million subscribers across Spotify and YouTube, Rogan reaches one of the largest male audiences in media — roughly 80% of his listeners are men.
This reach helps explain why U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. chose Rogan's podcast in late February to preview a shift in federal policy.

THE WOLVERINE STACK
Rogan has emerged as one of the most visible public advocates of these compounds, discussing BPC-157 — part of the so-called "wolverine stack."
"The pain was gone in two weeks."
— Joe Rogan on BPC-157Rogan said he began experimenting with BPC-157 to treat elbow tendinitis. After beginning injections, the pain was gone in two weeks.
Analysts widely project that the global GLP-1 category could exceed $100 billion annually before the end of the decade.
THE PARALLEL MARKET
As pharmaceutical companies were building this blockbuster class of medicines, a parallel peptide marketplace was developing outside the traditional regulatory framework.
WHAT ARE PEPTIDES?
Peptides are short chains of amino acids that function throughout the body as signaling molecules. Many naturally occurring hormones, including insulin and GLP-1, are peptides.
COMPOUNDS IN CIRCULATION
Online forums and fitness influencers routinely discuss these compounds for athletic recovery, sexual performance, and improved sleep quality.
THE PARALLEL ECOSYSTEM
A parallel ecosystem of longevity clinics and telehealth providers has emerged offering supervised peptide therapy programs, often costing patients several thousand dollars per year.
BUT ARE THEY SAFE?
The convergence of influencer demand, a booming GLP-1 market, and shifting federal policy is creating one of the most significant inflection points in modern health and wellness.
THE GOLD RUSH IS HERE. ARE YOU POSITIONED FOR IT?
"The unregulated Wild West is closing. The regulated, professional-channel peptide market is just opening — creating one of the biggest health and wellness opportunities of the decade."
— Steve Madden, Medical Marketing & Media, March 2026Your area may still be available
















